Cite this: Fibroids: Medical Therapy, Not Hysterectomy, Should Be First Treatment Choice - Medscape - November 11, 2024. Comments Commenting is limited to medical professionals.

Depot forms of gonadotropin-releasing hormone (GnRH) agonists are approved for short-term preoperative therapy for fibroids, cause amenorrhea in nearly 90% of patients, and reduce uterine volume ...

This therapy is indicated for management of heavy uterine bleeding for people who haven’t experienced menopause with systemic uterine fibroids. While it’s “extremely rare” for fibroids to transform ...

Academy Award-winning actress Lupita Nyong’o stepped away from the big screen Tuesday and onto Capitol Hill, joining members of the Congressional Black Caucus to call for urgent action on uterine ...

At 2 years, women who had received relugolix combination therapy for 52 weeks and then withdrew therapy continued to have less menstrual blood loss and pain caused by uterine fibroids, researchers ...

It’s an Atlanta-based, women-led organization where those dealing with fibroids can share their stories and raise awareness about the prevalence of the growths.

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the opportunity as a call to action on Capitol Hill.

At 2 years, women who had received relugolix combination therapy for 52 weeks and then withdrew therapy continued to have less menstrual blood loss and pain caused by uterine fibroids, researchers ...

Dr. Soyini Hawkins, a minimally invasive surgeon and founder of the Fibroid and Pelvic Wellness Center of Georgia, is working to expand treatment options for women with uterine fibroids and reduce the ...

AbbVie phase 2b study of elagolix with or without add-back therapy meets primary efficacy endpoint of reduced heavy menstrual bleeding in women with uterine fibroids ... Fibroids can be asymptomatic, ...

At six months, a dosage of 300mg twice daily of elagolix in combination with low-dose hormone therapy (estradiol 1.0 mg / norethindrone acetate 0.5 mg) achieved the primary study endpoint of ...